<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>19(4)</volume><submitter>Liu LJ</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>To investigate the effects of Tongmai Yangxin Pill (TMYXP) combined with metoprolol tartrate or metoprolol alone for the treatment of premature ventricular complex (PVC) in patients with symptomatic frequent PVC.&lt;h4>Methods&lt;/h4>A total of 584 patients with symptomatic frequent PVC were randomly assigned (in a 1:1 ratio) into two groups: study group [&lt;i>n&lt;/i> = 292, TMYXP (40 pills twice/day, orally) combined with metoprolol tartrate (25 mg twice/day, orally)] and control group [&lt;i>n&lt;/i> = 292, metoprolol tartrate (25 mg twice/day, orally) plus placebo pill (40 pills twice/day, orally)]. The total treatment period was eight weeks.&lt;h4>Results&lt;/h4>After eight weeks of treatment, the total effective rate of reduction of PVC in the study group and the control group were 76.4% </pubmed_abstract><journal>Journal of geriatric cardiology : JGC</journal><pagination>284-291</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9068592</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Tongmai Yangxin Pill combined with metoprolol or metoprolol alone for the treatment of symptomatic premature ventricular complex: a multicenter, randomized, parallel-controlled clinical study.</pubmed_title><pmcid>PMC9068592</pmcid><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Hua Q</pubmed_authors><pubmed_authors>Zhu GH</pubmed_authors><pubmed_authors>Sun XP</pubmed_authors><pubmed_authors>Liu LJ</pubmed_authors><pubmed_authors>Luo HY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tongmai Yangxin Pill combined with metoprolol or metoprolol alone for the treatment of symptomatic premature ventricular complex: a multicenter, randomized, parallel-controlled clinical study.</name><description>&lt;h4>Objective&lt;/h4>To investigate the effects of Tongmai Yangxin Pill (TMYXP) combined with metoprolol tartrate or metoprolol alone for the treatment of premature ventricular complex (PVC) in patients with symptomatic frequent PVC.&lt;h4>Methods&lt;/h4>A total of 584 patients with symptomatic frequent PVC were randomly assigned (in a 1:1 ratio) into two groups: study group [&lt;i>n&lt;/i> = 292, TMYXP (40 pills twice/day, orally) combined with metoprolol tartrate (25 mg twice/day, orally)] and control group [&lt;i>n&lt;/i> = 292, metoprolol tartrate (25 mg twice/day, orally) plus placebo pill (40 pills twice/day, orally)]. The total treatment period was eight weeks.&lt;h4>Results&lt;/h4>After eight weeks of treatment, the total effective rate of reduction of PVC in the study group and the control group were 76.4% </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-06-01T02:04:29.542Z</modification><creation>2025-06-01T02:04:29.542Z</creation></dates><accession>S-EPMC9068592</accession><cross_references><pubmed>35572220</pubmed><doi>10.11909/j.issn.1671-5411.2022.04.008</doi></cross_references></HashMap>